These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 27056069)

  • 1. Chemohyperthermia in non-muscle-invasive bladder cancer: An overview of the literature and recommendations.
    Liem EI; Crezee H; de la Rosette JJ; de Reijke TM
    Int J Hyperthermia; 2016 Jun; 32(4):363-73. PubMed ID: 27056069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intravesical instillations in non-muscle-invasive bladder cancer (NMIBC). Prospects for thermochemotherapy].
    Irani J
    Prog Urol; 2016 Nov; 26(14):860-864. PubMed ID: 27712914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravesical radiofrequency-induced hyperthermia combined with chemotherapy for non-muscle-invasive bladder cancer.
    van Valenberg H; Colombo R; Witjes F
    Int J Hyperthermia; 2016 Jun; 32(4):351-62. PubMed ID: 26905963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chemohyperthermia using MMC in non-muscle-invasive bladder cancer: Current status and future perspectives.].
    Coenen JJMJH; van Valenberg FJP; Arends TJH; Witjes JA
    Arch Esp Urol; 2018 May; 71(4):400-408. PubMed ID: 29745929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of hyperthermia as a treatment for non-muscle invasive bladder cancer.
    Bahouth Z; Halachmi S; Moskovitz B; Nativ O
    Expert Rev Anticancer Ther; 2016; 16(2):189-98. PubMed ID: 26618756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of a combined regimen with intravesical chemotherapy and hyperthermia in the management of non-muscle-invasive bladder cancer: a systematic review.
    Lammers RJ; Witjes JA; Inman BA; Leibovitch I; Laufer M; Nativ O; Colombo R
    Eur Urol; 2011 Jul; 60(1):81-93. PubMed ID: 21531502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Device-assisted intravesical therapy for non-muscle invasive bladder cancer.
    Hendricksen K
    Transl Androl Urol; 2019 Feb; 8(1):94-100. PubMed ID: 30976573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of bladder heating technology: matching capabilities with clinical requirements.
    Stauffer PR; van Rhoon GC
    Int J Hyperthermia; 2016 Jun; 32(4):407-16. PubMed ID: 26939993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravesical radiofrequency induced hyperthermia enhances mitomycin C accumulation in tumour tissue.
    van Valenberg FJP; van der Heijden AG; Lammers RJM; Falke J; Arends TJH; Oosterwijk E; Witjes JA
    Int J Hyperthermia; 2018 Nov; 34(7):988-993. PubMed ID: 29191126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravesical mitomycin C combined with hyperthermia for patients with T1G3 transitional cell carcinoma of the bladder.
    Halachmi S; Moskovitz B; Maffezzini M; Conti G; Verweij F; Kedar D; Sandri SD; Nativ O; Colombo R
    Urol Oncol; 2011; 29(3):259-64. PubMed ID: 19395285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravesical Chemotherapy and Chemohyperthermia in Non-Muscle-Invasive Bladder Cancer; An Overview on Drug Administration Technologies and Pharmacokinetics.
    Campodonico F; Di Stasi S; Lev GM; Terrone C; Bongiovanni L; Mattioli F; Pagliarulo V; Introini C
    Curr Drug Metab; 2017; 18(7):657-665. PubMed ID: 28460622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary European results of local microwave hyperthermia and chemotherapy treatment in intermediate or high risk superficial transitional cell carcinoma of the bladder.
    van der Heijden AG; Kiemeney LA; Gofrit ON; Nativ O; Sidi A; Leib Z; Colombo R; Naspro R; Pavone M; Baniel J; Hasner F; Witjes JA
    Eur Urol; 2004 Jul; 46(1):65-71; discussion 71-2. PubMed ID: 15183549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder carcinoma.
    Friedrich MG; Pichlmeier U; Schwaibold H; Conrad S; Huland H
    Eur Urol; 2007 Oct; 52(4):1123-29. PubMed ID: 17383080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined chemohyperthermia: 10-year single center experience in 160 patients with nonmuscle invasive bladder cancer.
    Arends TJ; van der Heijden AG; Witjes JA
    J Urol; 2014 Sep; 192(3):708-13. PubMed ID: 24704017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining Mitomycin C and Regional 70 MHz Hyperthermia in Patients with Nonmuscle Invasive Bladder Cancer: A Pilot Study.
    Geijsen ED; de Reijke TM; Koning CC; Zum Vörde Sive Vörding PJ; de la Rosette JJ; Rasch CR; van Os RM; Crezee J
    J Urol; 2015 Nov; 194(5):1202-8. PubMed ID: 26143111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recirculant hyperthermic IntraVEsical chemotherapy (HIVEC) in intermediate-high-risk non-muscle-invasive bladder cancer.
    Sousa A; Piñeiro I; Rodríguez S; Aparici V; Monserrat V; Neira P; Carro E; Murias C; Uribarri C
    Int J Hyperthermia; 2016 Jun; 32(4):374-80. PubMed ID: 26915466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot clinical trial of intravesical mitomycin-C and external deep pelvic hyperthermia for non-muscle-invasive bladder cancer.
    Inman BA; Stauffer PR; Craciunescu OA; Maccarini PF; Dewhirst MW; Vujaskovic Z
    Int J Hyperthermia; 2014 May; 30(3):171-5. PubMed ID: 24490762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectivity of intravescical thermo-chemotherapy prophylaxis for patients with high recurrence and progression risk for non-muscle invasive bladder cancer.
    Gözen AS; Umari P; Scheitlin W; Su FE; Akin Y; Rassweiler J
    Arch Ital Urol Androl; 2017 Jun; 89(2):102-105. PubMed ID: 28679178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of bacillus Calmette-Guerin refractory non-muscle invasive bladder cancer.
    Turker P; Turkeri L
    Arch Esp Urol; 2013 Nov; 66(9):833-40. PubMed ID: 24231293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is thermochemotherapy with the Synergo system a viable treatment option in patients with recurrent non-muscle-invasive bladder cancer?
    Kiss B; Schneider S; Thalmann GN; Roth B
    Int J Urol; 2015 Feb; 22(2):158-62. PubMed ID: 25339291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.